BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 14993986)

  • 1. [Clinical and research advances in oral AIDS].
    Chou L
    Shanghai Kou Qiang Yi Xue; 2001 Sep; 10(3):193-5. PubMed ID: 14993986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AIDS and the gateway of the body.
    Bandyopadhyay P; Bhowal RN; Sikdar SN; Roy AK; Roy JG; Bandyopadhyay D; Pal NC; Chatterjee BD
    J Indian Med Assoc; 1994 Jan; 92(1):17-9. PubMed ID: 8207272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of PI and NNRTI HAART-based therapy on oral lesions of Brazilian HIV-infected patients.
    Ortega KL; Vale DA; Magalhães MH
    J Oral Pathol Med; 2009 Jul; 38(6):489-94. PubMed ID: 19453845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk indicators for oral candidiasis and oral hairy leukoplakia in HIV-infected adults.
    Chattopadhyay A; Caplan DJ; Slade GD; Shugars DC; Tien HC; Patton LL
    Community Dent Oral Epidemiol; 2005 Feb; 33(1):35-44. PubMed ID: 15642045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral manifestations of AIDS: an overview.
    van der Waal I; Schulten EA; Pindborg JJ
    Int Dent J; 1991 Feb; 41(1):3-8. PubMed ID: 2004836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An atlas of HIV-associated oral lesions: a new classification and diagnostic criteria.
    Wiebe CB; Epstein JB
    J Can Dent Assoc; 1997 Apr; 63(4):288-9, 292-4. PubMed ID: 9125844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of human herpesvirus 8 infection and interferon-gamma response in cutaneous lesions of Kaposi sarcoma differ among human immunodeficiency virus-infected and uninfected individuals.
    Guedes F; de Andrade HF; Fernandes ER; Tuon FF; Brasil RA; Pagliari C; Duarte MI
    Br J Dermatol; 2008 Sep; 159(4):839-46. PubMed ID: 18644020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral hairy leukoplakia: an Epstein-Barr virus-associated disease of patients with HIV.
    Walling DM
    Res Initiat Treat Action; 2000 Dec; 6(4):10-5. PubMed ID: 11708168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral manifestations of HIV infection in relation to clinical and CD4 immunological status in northern and southern Thai patients.
    Kerdpon D; Pongsiriwet S; Pangsomboon K; Iamaroon A; Kampoo K; Sretrirutchai S; Geater A; Robison V
    Oral Dis; 2004 May; 10(3):138-44. PubMed ID: 15089922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral HIV lesions and oral health behaviour of HIV-positive patients attending the Queen Elizabeth II Hospital, Maseru, Lesotho.
    Kamiru HN; Naidoo S
    SADJ; 2002 Dec; 57(11):479-82. PubMed ID: 12674869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral candidosis and oral hairy leukoplakia as predictors of HAART failure in Brazilian HIV-infected patients.
    Miziara ID; Weber R
    Oral Dis; 2006 Jul; 12(4):402-7. PubMed ID: 16792726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cutaneous manifestations of AIDS].
    Marrakchi H; Mokhtar I; Zarrouk H; Daghfous M; Kamoun MR
    Tunis Med; 1993 Mar; 71(3):119-22. PubMed ID: 8351723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral lesions in HIV infected individuals from Ribeirão Preto, Brazil.
    Lourenço AG; Figueiredo LT
    Med Oral Patol Oral Cir Bucal; 2008 May; 13(5):E281-6. PubMed ID: 18449110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of oral lesions in HIV patients related to CD4 cell count and viral load in a Venezuelan population.
    Bravo IM; Correnti M; Escalona L; Perrone M; Brito A; Tovar V; Rivera H
    Med Oral Patol Oral Cir Bucal; 2006 Jan; 11(1):E33-9. PubMed ID: 16388291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Epstein-Barr virus replication on Langerhans cells in pathogenesis of oral hairy leukoplakia.
    Walling DM; Flaitz CM; Hosein FG; Montes-Walters M; Nichols CM
    J Infect Dis; 2004 May; 189(9):1656-63. PubMed ID: 15116302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term prognosis of HIV-infected patients with Kaposi sarcoma treated with pegylated liposomal doxorubicin.
    Martín-Carbonero L; Palacios R; Valencia E; Saballs P; Sirera G; Santos I; Baldobí F; Alegre M; Goyenechea A; Pedreira J; González del Castillo J; Martínez-Lacasa J; Ocampo A; Alsina M; Santos J; Podzamczer D; González-Lahoz J;
    Clin Infect Dis; 2008 Aug; 47(3):410-7. PubMed ID: 18582203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral lesions in HIV-positive patients in Georgia.
    Kakabadze T; Rukhadze N; Mshvidobadze K; Lomtadze M; Kandelaki G
    Georgian Med News; 2008 Dec; (165):60-5. PubMed ID: 19124919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Classification, diagnostic criteria, and treatment recommendations for orofacial manifestations in HIV-infected pediatric patients. Collaborative Workgroup on Oral Manifestations of Pediatric HIV Infection.
    Ramos-Gomez FJ; Flaitz C; Catapano P; Murray P; Milnes AR; Dorenbaum A
    J Clin Pediatr Dent; 1999; 23(2):85-96. PubMed ID: 10204447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral manifestations of HIV disease.
    Reznik DA
    Top HIV Med; 2005 Dec-2006 Jan; 13(5):143-8. PubMed ID: 16377852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.